Over the past few months, San Diego-based Avidity Biosciences Inc. reported multiple positive datasets from its three clinical-stage programs in rare muscle diseases. It is preparing for ...

Avidity Science’s Duo™ II.I benchtop water-purification system produces both Type 2 (de-ionised) and Type 1 (UltraPure) water from a single, compact unit. Built in the UK at a facility in Long Crendon ...

Dr Alfredo Carpineti (he/him) is an astrophysicist and communicator, passionate about science (almost a given) but also art, history, reading, cooking, and travelling. Alfredo mainly covers ...

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...

Most recently, Lohse was CEO of Avidity Science AmeriWater, which is backed by Edgewater Capital Partners, has named Doug Lohse as CEO.

$250,000 grant to bolster Life Science Cares San Diego 2024 grantmaking portfolio and support volunteer programs To kick off partnership, Avidity collaborates with Life Sciences Cares to host ...

To mark Avidity’s pledge, the Life Science Cares San Diego team partnered with Avidity to host students from San Diego’s Monarch School, the only public community school that exclusively ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning, it’s Meghana today! Some gene therapy talk: Pfizer’s gene ...

Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors.

ATS Completes Acquisition Of Avidity ScienceATS Corporation (TSX and NYSE: ATS) ("ATS" or the "Company"), today announced the successful completion of its acquisition of Avidity Science, LLC ("Avidity ...